Sentence examples for cost of bleeding from inspiring English sources

Although the cost of long-term prophylaxis was found to be higher with VWF with a low FVIII content, the cost per bleeding episodes per year was considerably reduced (in Case 1) or eliminated (in Cases 2 4) with VWF with a low FVIII content with respect to VWF/FVIII concentrates (Table 1, column 6: Cost of bleeding episodes per year).

The primary objectives of the present French hospital database analysis were: (1) to estimate the frequency of surgical DRGs associated with blood or blood constituent transfusions administered to ≥10% of WB patients; and (2) to compare the estimated costs of bleeding episodes and transfusions required by these patients versus the costs of WoB patients drawn from similar surgical DRGs.

The use of topical haemostatic agents should consider several factors such as the type of surgical procedure, cost, severity of bleeding, coagulation status and each agent's specific characteristics.

Lastly, we did not analyse the influence of the sector on the costs consequences of bleeding because we thought it could be redundant with the patient's characteristics.

Pharmaceutical cost includes both the yearly cost of treatment for long-term prophylaxis and the cost of treatment of bleeding episodes with concentrates (replacement therapy).

The cost of bleeds was estimated by taking a weighted average of the relevant cost with and without complications.

It turns out that the currently observed allele frequency, as well as distribution, could only be explained when there is a heterozygote advantage and an advantage for homozygotes with bleeding alleles, and the costs in fitness of bleeding counts half of pathogenic infections.

The annual cost of treating bleeding episodes with rFVIIa is ∼ 1 million pounds/child in the United Kingdom, which makes prophylaxis untenable on economic grounds for all but the wealthiest countries.

Evaluation of systemic thrombolysis has shown effective thrombolysis and a likely reduction in PTS but at the cost of increased risk of bleeding complications.

Anticoagulant prophylaxis should be selectively administered given the associated risk of bleeding, cost, and modest benefits for some patients.

Antithrombotic treatments are widely used in post-myocardial infarction patients to reduce thromboembolic risk, but at the cost of increased risk of bleeding.